Efficacy of an individualized adherence support program with contingent reinforcement among nonadherent HIV-positive patients: Results from a randomized trial

Journal of the International Association of Physicians in AIDS Care

Volumn 5, Issue 4, 2006, Pages 143-150

  Javanbakht, Marjan ^a   Prosser, Paul ^a   Grimes, Tim ^a   Weinstein, Michael ^a   Farthing, Charles ^a  

^a AIDS HEALTHCARE FOUNDATION   (United States)

Author keywords

adherence; antiretroviral therapy; compliance; contingency management; HIV AIDS; intervention

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT REFUSAL; VIROLOGY;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; PROSPECTIVE STUDIES; RNA, VIRAL; TREATMENT REFUSAL;

EID: 39049194146     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109706291706     Document Type: Article

References (32)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 ; 338: 853-860. (Pubitemid 28135961)
2. Garcia DO, Knobel H, Carmona A, Guelar A, Lopez-Colomes JL, Cayla JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002 ; 30: 105-110. (Pubitemid 34506694)
3. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000 ; 133: 21-30. (Pubitemid 30432540)
4. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999 ; 13: 1763-1769. (Pubitemid 30015725)
5. Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001 ; 26: 82-92. (Pubitemid 32115053)
6. Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patient's understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr. 2001 ; 28: 124-131. (Pubitemid 32971059)
7. Kleeberger CA, Buechner J, Palella F, et al. Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study. AIDS. 2004 ; 18: 683-688. (Pubitemid 38393468)
8. Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003 ; 114: 573-580. (Pubitemid 36577260)
9. Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002 ; 17: 756-765. (Pubitemid 35286241)
10. Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 2002 ; 16: 767-774. (Pubitemid 34274467)
11. Stone VE, Mansourati FF, Poses RM, Mayer KH. Relation of physician specialty and HIV/AIDS experience to choice of guideline-recommended antiretroviral therapy. J Gen Intern Med. 2001 ; 16: 360-368. (Pubitemid 34205653)
12. Gao X, Nau DP, Rosenbluth SA, Scott V, Woodward C. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care. 2000 ; 12: 387-398. (Pubitemid 30618183)
13. Johnson MO, Catz SL, Remien RH, et al. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project. AIDS Patient Care STDS. 2003 ; 17: 645-656. (Pubitemid 38031552)
14. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000 ; 12: 255-266. (Pubitemid 30426745)
15. Deeks SG, Hecht FM, Swanson M, et al. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy. AIDS. 1999 ; 13: F35 - F43.
16. Knobel H, Guelar A, Carmona A, et al. Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. AIDS Patient Care STDS. 2001 ; 15: 193-199. (Pubitemid 32374225)
17. Wit FW, van Leeuwen R, Weverling GJ, et al. Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons. J Infect Dis. 1999 ; 179: 790-798. (Pubitemid 29159323)
18. Touloumi G, Paparizos V, Sambatakou H, et al. Virological and immunological response to HAART therapy in a communitybased cohort of HIV-1-positive individuals. HIV Clin Trials. 2001 ; 2: 6-16. (Pubitemid 32181744)
19. Safren SA, Otto MW, Worth JL, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther. 2001 ; 39: 1151-1162. (Pubitemid 32743136)
20. Rigsby MO, Rosen MI, Beauvais JE, et al. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J Gen Intern Med. 2000 ; 15: 841-847. (Pubitemid 32011833)
21. Tuldra A, Fumaz CR, Ferrer MJ, et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2000 ; 25: 221-228. (Pubitemid 32010124)
22. Rawlings MK, Thompson MA, Farthing CF, et al. Impact of an educational program on efficacy and adherence with a twicedaily lamivudine/zidovudine/ abacavir regimen in underrepresented HIV-infected patients. J Acquir Immune Defic Syndr. 2003 ; 34: 174-183. (Pubitemid 37248914)
23. Goujard C, Bernard N, Sohier N, et al. Impact of a patient education program on adherence to HIV medication: a randomized clinical trial. J Acquir Immune Defic Syndr. 2003 ; 34: 191-194. (Pubitemid 37248916)
24. Murphy DA, Lu MC, Martin D, Hoffman D, Marelich WD. Results of a pilot intervention trial to improve antiretroviral adherence among HIV-positive patients. J Assoc Nurses AIDS Care. 2002 ; 13: 57-69.
25. Bandura A. Social Foundation of Thoughts and Actions. Eaglewood Cliff, NJ: Prentice-Hall, 1986.
26. Budney AJ, Higgins ST, Delaney DD, Kent L, Bickel WK. Contingent reinforcement of abstinence with individuals abusing cocaine and marijuana. J Appl Behav Anal. 1991 ; 24: 657-665.
27. Higgins ST, Wong CJ, Badger GJ, Ogden DE, Dantona RL. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. J Consult Clin Psychol. 2000 ; 68: 64-72. (Pubitemid 30120951)
28. Petry NM, Martin B, Cooney JL, Kranzler HR. Give them prizes, and they will come: contingency management for treatment of alcohol dependence. J Consult Clin Psychol. 2000 ; 68: 250-257.
29. Knobel H, Carmona A, Lopez JL, et al. Adherence to very active antiretroviral treatment: impact of individualized assessment [in Spanish]. Enferm Infecc Microbiol Clin. 1999 ; 17: 78-81. (Pubitemid 29129643)
30. Volmink J, Garner P. Systematic review of randomized controlled trials of strategies to promote adherence to tuberculosis treatment. BMJ. 1997 ; 315: 1403-1406. (Pubitemid 27510721)
31. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000 ; 23: 386-395. (Pubitemid 30431595)
32. Eldred LJ, Wu AW, Chaisson RE, Moore RD. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 ; 18: 117-125.